Apple To $370? Here Are 10 Top Analyst Forecasts For Thursday
Analysts cut targets for AAPL, CHWY, COO, TYRA and CNM; raised DLR, DPZ, SIG, while ratings stayed unchanged.
Stocks · News reference
InnovAge shares climbed 10.25% after hours after fourth-quarter revenue beat estimates and the company issued fiscal 2027 guidance.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Analysts cut targets for AAPL, CHWY, COO, TYRA and CNM; raised DLR, DPZ, SIG, while ratings stayed unchanged.
Analysts cut targets for CAN, TTAN and BSX, while raising targets for BRZE, VRNS, IMAX, PHVS and CHYM. Ratings largely remained positive.
Keybanc analyst Matthew Gillmor maintains InnovAge Holding (NASDAQ:INNV) with a Overweight and raises the price target from $13 to $14.